Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
- DOI
- 10.33393/grhta.2024.3041
- Published
- 2024 Jan-Dec
- Container
- Global & regional health technology assessment
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.33393/grhta.2024.3041,
title = {Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.},
author = {Abad MR and Alerany C and Alsina L and Granados EL and Neth O and Poveda JL and Rivière JG and Rodríguez-Gallego C and Tutein Nolthenius JB and Figueiredo R and Labazuy SS and Gil A},
year = {2024},
journal = {Global \& regional health technology assessment},
doi = {10.33393/grhta.2024.3041},
url = {https://doi.org/10.33393/grhta.2024.3041}
}RIS
TY - JOUR TI - Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders. AU - Abad MR AU - Alerany C AU - Alsina L AU - Granados EL AU - Neth O AU - Poveda JL AU - Rivière JG AU - Rodríguez-Gallego C AU - Tutein Nolthenius JB AU - Figueiredo R AU - Labazuy SS AU - Gil A PY - 2024 JO - Global & regional health technology assessment DO - 10.33393/grhta.2024.3041 UR - https://doi.org/10.33393/grhta.2024.3041 ER -
APA
MR, A., C, A., L, A., EL, G., O, N., JL, P., JG, R., C, R., JB, T. N., R, F., SS, L., & A, G. (2024). Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.. Global & regional health technology assessment. https://doi.org/10.33393/grhta.2024.3041
Source records
- pubmed · retrieved 2026-09-25T18:27:08.809Z